MCh Pediatric Orthopedics: Admission, Medical School, Fees, Eligibility Criteria

Published Date: 06 Mar 2023

The Master Chirurgiae in Pediatric Orthopedics, also known as MCh Pediatric Orthopedics or MCh in Pediatric Orthopedics, is the highest degree...

Read Full News

Latest News

Study Finds Huge Regional Variability in 'Low-Value' Orthopedic Services for Vets

— Patients in one place may get Medicare-paid procedures 10 times as often as elsewhere

Study 'Challenges' Standard of Prolonged Antibiotics for Orthopedic Infections

— Local antibiotic implants during surgery may have helped shorten postoperative systemic regimens

One Active Joint Left in Inflammatory Arthritis: What to Do?

Despite being a clinical scenario familiar to any rheumatologist, little evidence exists to guide treatment decisions for inflammatory arthritis limited to a single major joint.

AbbVie's Blood Cancer Therapy Lowers Disease Progression, Death Risk in Trial

AbbVie said on Thursday its therapy for a type of blood cancer has improved patients' response rate ⁠to treatment and reduced the risk of disease progression or death,...

Less Frequent Monitoring May Be Safe in Patients on MTX

For patients on methotrexate, routine monitoring every 6 months vs 3 months is not linked to an increase in laboratory or blood count abnormalities.

Gout Tied to Elevated Fracture Risk; Drug Adherence Helps

A recent diagnosis of gout is associated with an increased risk for fractures, and high adherence to allopurinol may help mitigate this elevated risk.

Todays Updates

The HCPFive: Top News for Healthcare Providers from the Week of 10/25

The HCPFive: Top News for Healthcare Providers from the Week of 10/25

Q&A: Asthma Remission from Year 1 To Year 2 With Depemokimab

Q&A: Asthma Remission from Year 1 To Year 2 With Depemokimab

Deep TMS Reduces Suicidal Ideation by 70% in MDD, With Owen Muir, MD Owen Muir, MD, DFAACAP, FCTMSS

A secondary analysis found the SWIFT accelerated protocol eased suicidal ideation faster than standard daily deep TMS dosing in major depressive disorder.

Benitec Reports Positive Interim Results for BB-301 in Oculopharyngeal Muscular Dsytrophy Marco Meglio

Interim phase 1b/2a data showed all patients treated with high- or low-dose BB-301 for oculopharyngeal muscular dystrophy met formal response criteria.

This Week on NeurologyLive® — November 2, 2026 Isabella Ciccone, MPH

Here's some of what is coming soon to NeurologyLive® this week.

Zola-Cel and Treatment-Free Remission: What the BREAKFREE-2 Data Show Marco Meglio, Jeffrey Cohen, MD

Jeffrey Cohen, MD, professor of neurology and staff physician at the Cleveland Clinic Mellen Center for Multiple Sclerosis, discusses interim BREAKFREE-2 findings for zola-cel, a CD19-directed CAR T cell therapy, in relapsing and progressive MS.

ASN Kidney Week 2026 Recap: 8 Key Updates in Kidney Disease to Know

ASN Kidney Week 2026 Recap: 8 Key Updates in Kidney Disease to Know

Todays Updates

The HCPFive: Top News for Healthcare Providers from the Week of 10/25

The HCPFive: Top News for Healthcare Providers from the Week of 10/25

Q&A: Asthma Remission from Year 1 To Year 2 With Depemokimab

Q&A: Asthma Remission from Year 1 To Year 2 With Depemokimab

Deep TMS Reduces Suicidal Ideation by 70% in MDD, With Owen Muir, MD Owen Muir, MD, DFAACAP, FCTMSS

A secondary analysis found the SWIFT accelerated protocol eased suicidal ideation faster than standard daily deep TMS dosing in major depressive disorder.

Benitec Reports Positive Interim Results for BB-301 in Oculopharyngeal Muscular Dsytrophy Marco Meglio

Interim phase 1b/2a data showed all patients treated with high- or low-dose BB-301 for oculopharyngeal muscular dystrophy met formal response criteria.

This Week on NeurologyLive® — November 2, 2026 Isabella Ciccone, MPH

Here's some of what is coming soon to NeurologyLive® this week.

Zola-Cel and Treatment-Free Remission: What the BREAKFREE-2 Data Show Marco Meglio, Jeffrey Cohen, MD

Jeffrey Cohen, MD, professor of neurology and staff physician at the Cleveland Clinic Mellen Center for Multiple Sclerosis, discusses interim BREAKFREE-2 findings for zola-cel, a CD19-directed CAR T cell therapy, in relapsing and progressive MS.

ASN Kidney Week 2026 Recap: 8 Key Updates in Kidney Disease to Know

ASN Kidney Week 2026 Recap: 8 Key Updates in Kidney Disease to Know

Latest News

— Patients in one place may get Medicare-paid procedures 10 times as often as elsewhere

— Local antibiotic implants during surgery may have helped shorten postoperative systemic regimens

Despite being a clinical scenario familiar to any rheumatologist, little evidence exists to guide treatment decisions for inflammatory arthritis limited to a single major joint.

AbbVie said on Thursday its therapy for a type of blood cancer has improved patients' response rate ⁠to treatment and reduced the risk of disease progression or death,...

For patients on methotrexate, routine monitoring every 6 months vs 3 months is not linked to an increase in laboratory or blood count abnormalities.

A recent diagnosis of gout is associated with an increased risk for fractures, and high adherence to allopurinol may help mitigate this elevated risk.

News All Time

Rare Case of Multiple Myeloma in Teenage Girl

Successful use of affordable induction therapy with autologous stem cell transplantation

Multi-Joint Arthritis Bodes Poorly for Healthy Aging

Osteoarthritis extent tied to increased frailty, even after adjusting for physical activity

Can Creatine Help Non-Athletes? A Physical Therapist Weighs In

Creatine may have less risk than other supplements, but who might benefit is unclear

Synovitis Confirmed as Prognostic in Hand Osteoarthritis, Regardless of Subtype

— Doesn't matter whether it's in the first carpometacarpal or interphalangeal joints

Denosumab May Protect Joints in Adults With Osteoporosis

Starting denosumab is associated with a modestly lower risk of developing osteoarthritis than starting oral bisphosphonates among adults with osteoporosis.

Straight Talk on Scoliosis Screening in Primary Care

Pediatricians can and should screen for scoliosis, especially in teens who are still growing.

Real-World Strategies to Improve Multidisciplinary Care Coordination of TGCT

Real-World Strategies to Improve Multidisciplinary Care Coordination of TGCT

Real-World Strategies to Improve Multidisciplinary Care Coordination of TGCT

Real-World Strategies to Improve Multidisciplinary Care Coordination of TGCT

Did Your Patient’s Cane Kill Them?

Mobility assistance devices may be harmful if not prescribed properly

Trial Casts Doubt on Antibiotics for Refractory Low Back Pain

Now it's up to clinicians to sort out conflicting evidence

GLP-1 Drugs Tied to Lower Need for Knee Replacement

But what drives the apparent effect remains unknown. Is it the weight loss or other factors?

Top Pro Athletes Credit a Tiny New Scope for Their Faster Recoveries

There's little published research, but a small, flexible arthroscope is accumulating proponents

Cancer Diagnosis Delays During Screening Study; Benefits of Resistance Training

Also in TTHealthWatch: GLP-1 agonists and knee replacement

Woman's Ice-Skating Fall Produces Striking X-Ray, Rare Forearm Break

While Monteggia fracture is uncommon in adults, early intervention is crucial

The World Cup Is a Celebration of Sport. It's Also a Warning About Climate Change.

The tournament is a preview for how outdoor activities are being reshaped globally

Why Some 'Old' Soccer Players Like Messi, Ronaldo Can Still Kick It in the World Cup

Advancements in training and recovery means elite athletes are playing longer than ever before

Recommended News For You

Research Indicates that First-Line Immunotherapy Is Enough for Elderly NSCLC Patients?

The standard for high-risk prostate cancer is supported by a study using high-dose RT and long-term ADT.

younger kidney cancer survivors are more susceptible to heart problems.

New drug combination shows good results in patients with HPV-negative head and neck cancer

A study suggests that you should disregard the "pack-years" when determining your eligibility for lung cancer screening.

The Effect of Common Steroids on Cancer Treatments.

FDA Approves Iberdomide Combo for Multiple Myeloma

Recommended Articles For You

Risk Assessment of Hemolysis During Mechanical Circulatory Support 

Base Editing for Rare Hematologic Disease: Advances, Mechanisms, and Clinical Implications 

Metabolic Competition Within the Tumor Ecosystem: Mechanisms, Clinical Relevance, and Therapeutic Advances 

Integrated Models in Hematology for Specialists 

Whats more on Hidoc Dr.

Medical Updates
KOL Videos
Surveys
Events

Daily news to keep you up to date

Gain valuable insights with our in-depth KOL Video discussions

Participate and win cash vouchers

Get updates on the latest events happening around the world
Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Schizophrenia patients are motivated by music therapy.

2.

Pediatric high-grade gliomas: Research reveals effective targeting with avapritinib

3.

Cancer deaths expected to rise to over 18 million in 2050, nearly 75% more than in 2024

4.

Breast Cancer Genetic Testing Need in Black Women Identified

5.

Products for Intimate Care and Cancer; Boost for Colorectal Cancer Stool Tests; Ultrasonic Biopsy?

1.

Clonal Hematopoiesis and Healthy Aging: Clinical Implications, Mechanisms, and Emerging Perspectives

2.

Understanding Sideroblastic Anemia and its Symptoms 

3.

Targeted Degradation in Leukemia: Mechanisms, Clinical Implications, and Therapeutic Advances

4.

Age-Dependent Megakaryocyte Development: Mechanisms, Clinical Implications, and Future Directions

5.

Unlocking the Potential of Trabectedin: A Novel Therapy for Cancer Treatment

1.

International Conference on Innovations in Critical Care for Oncology and Cardiology

2.

International Conference on Oncology, Cardiology and Critical Care Policy

3.

International Conference on Oncology, Cancer Prevention and Public Health

4.

International Conference on Cancer Nursing and Rehabilitation Strategies

5.

International Conference on Best Practices in Oncology, Cardiology and Critical Care

1.

Understanding the Multifaceted Advantages of CDK4/6 Inhibitors in HR+/HER2- PALOMA 2 Study.

2.

First-Line Maintenance Therapy for Metastatic Urothelial Carcinoma: Bridging Clinical Practice and Trials

3.

Common Cancer Myths Debunked

4.

Blood Clotting Disorders Explained

5.

Understanding Blood Clotting Disorders

Fastest Growing Medical Platform for Doctors

Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801

Phone :
+1-415-463-3094

Email :
anishagadia@hidoc.co

Quick Links

Drug DatabaseDrug InteractionDiseases Database
KOL VideosKnowledge HubQuizzes
Medical UpdatesEventsAbout Us

© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
Home
Profile
Login
bot